Should therapeutic cannabis be regulated?

Can we lawfully buy and consume cannabis in France today? Yes and no. Yes, since the state has actually unwinded its regulations on CBD, including through the Minister of Health. And no, at the same time, since only products containing cannabidiol (CBD), an active substance that does not have the psychedelic results credited to THC, are thought about legal. Let us take stock of what is legal and what is not with regard to cannabis and CBD.

CBD is legal in France, but THC is not

Cannabis ought to not be confused with cannabidiol. Specifically since the second is legal in specific forms in France … While the other is not! Due to the fact that cannabidiol (understood by the acronym CBD) is just among the many active substances from the hemp plant, which does not have the psychedelic results of its cousin THC – the one that makes you “stone”.

In short, what is generally called “cannabis”, which contains high concentrations of THC (tetrahydrocannabinol) is still thought about a narcotic product. And therefore illegal in France as in numerous nations on earth. On the other hand, cannabis which offers pride of place to the cannabinoid called cannabidiol, it is legal as long as its THC levels do not surpass 0.2%.

Nevertheless, the legislation remains unclear in France on this subject. Presently, there is no law that makes it clear whether CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in an electronic cigarette. However it is likewise found in other forms (including oil or paste), without its purchase and intake being reprehensible … To attempt to make it simple, let’s say that CBD is not forbidden by French law, unlike THC

CBD vs THC.

Although CBD and THC are equivalent, they are extremely various. These are the best understood of the 500 cannabinoids found in hemp. And each has its specific results. THC is especially understood for its psychedelic homes: it triggers a change in the state of awareness by acting straight on the brain. By taking in cannabis abundant in THC, we “hover”: well-being, euphoria, relaxation … But likewise red eyes, dilated pupils and, in some cases, anxiety or even paranoia.

CBD has nothing to do with it. It is not euphoric. It does not cause anxiety or anxiety attacks. On the contrary: cannabidiol remains in the procedure of making its way by virtue of its beneficial therapeutic results. CBD helps eliminate pain and swelling, minimize anxiety, alleviate the suffering of victims of anxiety attacks and anxiety, and even treat specific illness (such as epilepsy or Alzheimer’s). In addition, it has a really low toxicity and presents (practically) no addicting danger, even if the lack of scientific research studies lowers these attributes to mere hypotheses.

Legalization of CBD in France: should we go even more?

Certainly, the legal development regarding CBD is positive, but whatever remains to be done. The health ministry wants to beware, and the government’s position on the matter resembles a balancing act. At the same time, the National Medicines Agency has actually plainly spoken out. We therefore look after the goat and the cabbage so as not to get too included, while the vaporized cannabidiol has actually been readily available in France for a few years already, making the most of the legal vagueness that persists.

Beyond the 0.2% THC limit licensed in marketed products, it ought to be remembered that only the liquid kind of CBD (meant for electric cigarettes) is actually legal. The purchase and intake of resin or cigarette smoking herb is therefore not regulated, especially since the THC level is often higher (around 15%). In addition, only making use of seeds and fibers is licensed in France. However what about midnight CBD oil, which enables you to delight in the advantages of the substance without exposing your lungs to possibly harmful smoke? What about CBD paste? On these subjects, there is radio silence.

In addition, composite CBD is thought about a “dietary supplement”, which prohibits presenting it as a medication. And make it an informed ad for users and clients. Regrettable, since, in the meantime, numerous prospective recipients are not making the most of it. It is therefore necessary to go even more and clarify things: more than a concern of consumer welfare, it is a matter of public health.

Scroll to top